Maverix Medical

Maverix Medical is dedicated to revolutionizing the diagnosis and treatment of lung cancer, with a mission to improve outcomes and save lives.  We aim to bring cutting-edge technologies and innovative solutions to the forefront of lung cancer care, empowering clinicians with accurate tools and personalized treatments.

Our Strategy

To build a portfolio and establish a network of healthcare providers, research institutions and industry partners to facilitate efficient and effective diagnosis and treatment of lung cancer.

  • The National Lung Screening trial validated that the majority of lung nodules detected on chest computed tomography (CT) are benign. Although low-dose computed tomography (CT) is an effective screening tool for lung cancer, implementing screening programs can be challenging. Identifying eligible patients, coordinating screening and follow-up processes, and handling incidental findings are some of the challenges associated with lung cancer screening.

  • Lung cancer is a heterogeneous disease and can be challenging to diagnose. Tumors can have different genetic mutations and respond differently to treatment.

  • In lung cancer treatments, minimally invasive procedures often result in lower complication rates, faster recovery times and preservation of lung function.

  • Lung cancer and its treatment can have a significant impact on physical functioning and can impact a patient’s ability to perform daily activities. By effectively managing the range of symptoms, we can enhance well-being and overall quality of care.

Pages and Publications